552. Effect of Lactococcus lactis strain plasma (LC- Plasma) on immune response and symptoms in patients with mild COVID-19. Result of the multicenter, double- blinded, randomized controlled trial (PLATEAU study)
Abstract Background The COVID-19 epidemic has been repeated worldwide; however, easily accessible treatment options for patients with mild COVID-19 remain limited. Since the Lactococcus lactis strain plasma (LC- Plasma) enhances both the innate and acquired immune systems through the activation of p...
Gespeichert in:
Veröffentlicht in: | Open forum infectious diseases 2023-11, Vol.10 (Supplement_2) |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!